Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Guanethidine 10mg/1ml solution for injection ampoules
0205030N0AAAAAA
|
Guaneth monosulfate (Systemic) | Guanethidine monosulfate | Cardiovascular System | No data available |
|
Guanfacine 2mg tablets
0205020G0AAADAD
|
Guanfacine hydrochloride | Guanfacine hydrochloride | Cardiovascular System | No data available |
|
Gutron 2.5mg tablets
0207020Y0BBAAAE
|
Gutron | Midodrine hydrochloride | Cardiovascular System | No data available |
|
Gutron 5mg tablets
0207020Y0BBABAF
|
Gutron | Midodrine hydrochloride | Cardiovascular System | No data available |
|
Haemate P 1,000unit inj vials
0211000I0BMABAM
|
Haemate P | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Haemate P 500unit inj vials
0211000I0BMAAAB
|
Haemate P | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Haemoctin 1,000unit inj vials
0211000I0BRACAD
|
Haemoctin | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Haemoctin 250unit inj vials
0211000I0BRAAAE
|
Haemoctin | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Haemoctin 500unit inj vials
0211000I0BRABAC
|
Haemoctin | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Haemonine 1,000unit inj vials
0211000J0BGAAAF
|
Haemonine | Dried factor IX fraction | Cardiovascular System | No data available |
|
Haemonine 500unit inj vials
0211000J0BGABAE
|
Haemonine | Dried factor IX fraction | Cardiovascular System | No data available |
|
Helixate NexGen 1,000unit inj vials
0211000I0BNACAH
|
Helixate NexGen | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Helixate NexGen 2,000unit inj vials
0211000I0BNADAI
|
Helixate NexGen | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Helixate NexGen 250unit inj vials
0211000I0BNAAAF
|
Helixate NexGen | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Helixate NexGen 500unit inj vials
0211000I0BNABAG
|
Helixate NexGen | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Heparin calcium 12,500units/0.5ml inj pre-filled syringes
0208010N0AAAHAH
|
Heparin calcium | Heparin calcium | Cardiovascular System | No data available |
|
Heparin calcium 5,000units/0.2ml inj pre-filled syringes
0208010N0AAAFAF
|
Heparin calcium | Heparin calcium | Cardiovascular System | No data available |
|
Heparin sodium 100units/1ml solution for injection ampoules
0208010K0AABJBJ
|
Heparin sodium (Parenteral) | Heparin sodium | Cardiovascular System | No data available |
|
Heparin sodium 125,000units/5ml solution for injection vials
0208010K0AAA6A6
|
Heparin sodium (Parenteral) | Heparin sodium | Cardiovascular System | No data available |
|
Heparin sodium 20,000units/20ml inj ampoules
0208010K0AAAZAZ
|
Heparin sodium (Parenteral) | Heparin sodium | Cardiovascular System | No data available |
|
Heparin sodium 25,000units/5ml solution for injection vials
0208010K0AAA5A5
|
Heparin sodium (Parenteral) | Heparin sodium | Cardiovascular System | No data available |
|
Hepsal 50units/5ml patency solution ampoules
0208010P0BDAAAD
|
Hepsal | Heparin flushes | Cardiovascular System | No data available |
|
Hexopal 1g/5ml oral suspension
0206040AFBCACAC
|
Hexopal | Nicotinic acid derivatives | Cardiovascular System | No data available |
|
Hexopal 500mg tablets
0206040AFBCAAAA
|
Hexopal | Nicotinic acid derivatives | Cardiovascular System | No data available |
|
Hexopal Forte 750mg tablets
0206040AFBCABAB
|
Hexopal | Nicotinic acid derivatives | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.